Satyendra Singh

LiveDNA ID: 91.41407

12 Publications

0 Editorial Roles

0 Projects

About

Professional Summary

Satyendra is a postgraduate and is currently pursuing a PhD in Biochemistry from the Central University of Rajasthan. He is an enthusiastic researcher exploring drug discovery, vaccine development, miRNA-based therapies, Nanobody-peptide conjugates, and immune cell checkpoints for human diseases.

Education

Academic Background

Ph.D. Student Central University of Rajasthan, India Biochemistry | Completed: 2023
M.Sc. Central University of Rajasthan, India Biochemistry | Completed: 2020
B.Sc. Dr. Harisingh Gour University, Sagar, India Zoology and Chemistry | Completed: 2018

Publications (12)

Selected Scholarly Contributions

Systems-Driven Identification and Experimental Validation of Actinomycetes-Derived Secondary Metabolites as Promising Antileishmanial Agents Targeting Leishmania donovani Methionyl-tRNA Synthetase

Satyendra Singh, Kirti Baghel, Preshita Bhalerao, Tarun Kumar Bhatt, Dhaneswar Prusty, Vijay Kumar Prajapati

ACS Medicinal Chemistry Letters | Journal Article

10.1021/acsmedchemlett.6c00201

2026

The Routledge International Handbook of Disability and Global Health

Lieketseng Ned, Minerva Rivas Velarde, Satendra Singh, Leslie Swartz, Karen Soldatić

Book

10.4324/9781003228059

2024

Disability competencies for disability rights in the curriculum in the Global North and Global South

LuanJiao Hu, Kanchan Marcus, Stephanie D. Short, Satendra Singh

The Routledge International Handbook of Disability and Global Health | Book Chapter

10.4324/9781003228059-13

2024

Knocking on access doors

Sharad Philip, Shubha Nagesh, Satendra Singh

The Routledge International Handbook of Disability and Global Health | Book Chapter

10.4324/9781003228059-34

2024

Disability accommodations

Satendra Singh, Sharad Philip, Shubha Nagesh

The Routledge International Handbook of Disability and Global Health | Book Chapter

10.4324/9781003228059-35

2024

Exploring malaria parasite surface proteins to devise highly immunogenic multi-epitope subunit vaccine for Plasmodium falciparum

Preshita Bhalerao, Satyendra Singh, Vijay Kumar Prajapati, Tarun Kumar Bhatt

Journal of Genetic Engineering and Biotechnology | Journal Article

10.1016/j.jgeb.2024.100377

2024

Translational vaccinomics and structural filtration algorithm to device multiepitope vaccine for catastrophic monkeypox virus

Satyendra Singh, Abhishek Rao, Ketan Kumar, Amit Mishra, Vijay Kumar Prajapati

Computers in Biology and Medicine | Journal Article

10.1016/j.compbiomed.2022.106497

2023

Prediction of an immunogenic peptide ensemble and multi-subunit vaccine for Visceral leishmaniasis using bioinformatics approaches

Manu Kupani, Rajeev Kumar Pandey, Sharad Vashisht, Satyendra Singh, Vijay Kumar Prajapati, Sanjana Mehrotra

Heliyon | Journal Article

10.1016/j.heliyon.2023.e22121

2023

Multi-pathogen based chimeric vaccine to fight against COVID-19 and concomitant coinfections.

Ojha, R., S. Singh, N. Gupta, K. Kumar, A.K. Padhi and V.K. Prajapati,

Biotechnol. Lett., | Journal Article

10.1007/s10529-023-03380-0

Satyendra Singh

2023

Multifaceted mutational immunotherapeutic approach to design therapeutic mAbs to combat monkeypox disease via integrated screening algorithms and antibody engineering.

Singh, S., A. Rao, A. Mishra, A. Mishra and V.K. Prajapati,

Mol. Syst. Des. Eng., | Journal Article

10.1039/D3ME00059A

Satyendra Singh

2023

Chemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications.

Naik, B., V.S.K. Mattaparthi, N. Gupta, R. Ojha and P. Das et al.,

J. Biomol. Struct. Dyn., | Journal Article

10.1080/07391102.2021.1931451

Satyendra Singh

2022

High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment.

Naik, B., N. Gupta, R. Ojha, S. Singh, V.K.Prajapati and D. Prusty,

Int. J. Biol. Macromol., | Journal Article

10.1016/j.ijbiomac.2020.05.184

Satyendra Singh

2020